A Bifluorescent-Based Assay for the Identification of Neutralizing Antibodies against SARS-CoV-2 Variants of Concern In Vitro and In Vivo

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged at the end of 2019 and has been responsible for the still ongoing coronavirus disease 2019 (COVID-19) pandemic. Prophylactic vaccines have been authorized by the U.S. Food and Drug Administration (FDA) for the prevention of COVID-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiem, Kevin, Morales Vasquez, Desarey, Silvas, Jesus A., Park, Jun-Gyu, Piepenbrink, Michael S., Sourimant, Julien, Lin, Michelle J., Greninger, Alexander L., Plemper, Richard K., Torrelles, Jordi B., Walter, Mark R., de la Torre, Juan C., Kobie, James K., Ye, Chengjin, Martinez-Sobrido, Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549516/
https://www.ncbi.nlm.nih.gov/pubmed/34495697
http://dx.doi.org/10.1128/JVI.01126-21